Options: Hide MedDRA Preferred Terms
MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | |
---|---|---|---|---|---|
1 | 2 | ||||
Headache | Headache | 8% - 25% | 9% | x | x |
Pharyngitis | Pharyngitis | 5% - 27% | 4% | x | x |
Upper respiratory tract infection | Upper respiratory tract infection | 3% - 17% | 11% | x | x |
Rhinitis | Rhinitis | 3% - 15% | 9% | x | x |
Asthma | Asthma | 0% - 14% | 18% | x | x |
Back pain | Back pain | 1% - 4% | 1% | x | x |
Sinusitis | Sinusitis | 0% - 7% | 2% | x | x |
Pain | Pain | 1% - 5% | 1% | x | x |
Nausea | Nausea | 1% - 5% | 0% | x | x |
Dysphonia | Dysphonia | 0% - 6% | 2% | x | x |
Angioedema | Angioedema | x | x | ||
Bronchospasm | Bronchospasm | x | x | ||
Infection | Infection | x | x | ||
Cough | Cough | x | x | ||
Dysmenorrhoea | Dysmenorrhoea | x | x | ||
Dermatitis | Rash | x | x | ||
Rash | Rash | x | x | ||
Type IV hypersensitivity reaction | Type IV hypersensitivity reaction | x | x | ||
Urticaria | Urticaria | x | x | ||
Oropharyngeal candidiasis | Oropharyngeal candidiasis | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | ||||
---|---|---|---|---|---|
Asthma | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |